Amanda Lemos was notified of a potential out of competition drug test failure from USADA for a sample collected in November of 2017.
The fighter has now accepted a two year suspension from the United States Anti-Doping Agency (USADA).
USADA issued the following statement on the matter:
USADA announced today that UFC® athlete Amanda Lemos, of Belém, Brazil, has tested positive for a prohibited substance and accepted a two-year sanction for her anti-doping policy violation.
Lemos, 30, tested positive for stanozolol and its metabolite 16β-hydroxystanozolol following an out-of-competition urine test conducted on November 8, 2017. Stanozolol is a non-Specified Substance in the class of Anabolic Agents and prohibited at all times under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency Prohibited List.
Lemos’ two-year period of ineligibility, the standard sanction for a first offense involving a non-Specified Substance, began on November 8, 2017, the date her positive sample was collected.
Pursuant to the UFC Anti-Doping Policy, all UFC athletes serving a period of ineligibility for an anti-doping policy violation are required to continue to make themselves available for testing in order to receive credit for time completed under their sanction.
USADA conducts the year-round, independent anti-doping program for all UFC athletes. USADA is an independent, non-profit, non-governmental agency whose sole mission is to preserve the integrity of competition, inspire true sport, and protect the rights of clean athletes. In an effort to aid UFC athletes, as well as their support team members, in understanding the rules applicable to them, USADA provides comprehensive instruction on the UFC Anti-Doping Program website (https://ufc.USADA.org) regarding the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (https://ufc.globaldro.com), conducts educational sessions, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, and periodic athlete alerts.
USADA also makes available a number of ways to report the abuse of performance-enhancing drugs in sport in an effort to protect clean athletes and promote clean competition. Any tip can be reported using the USADA Play Clean Tip Center, by email at [email protected], by phone at 1877-Play Clean (1-877-752-9253) or by mail.
Lemos’ suspension is retroactive to the date of the test failure, which means she can compete inside the Octagon again starting on November 8 of 2019.
